9-137716669-A-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_024757.5(EHMT1):​c.129A>T​(p.Ala43Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.009 in 1,598,218 control chromosomes in the GnomAD database, including 829 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A43A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.041 ( 416 hom., cov: 32)
Exomes 𝑓: 0.0056 ( 413 hom. )

Consequence

EHMT1
NM_024757.5 synonymous

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.782

Publications

5 publications found
Variant links:
Genes affected
EHMT1 (HGNC:24650): (euchromatic histone lysine methyltransferase 1) The protein encoded by this gene is a histone methyltransferase that methylates the lysine-9 position of histone H3. This action marks the genomic region packaged with these methylated histones for transcriptional repression. This protein may be involved in the silencing of MYC- and E2F-responsive genes and therefore could play a role in the G0/G1 cell cycle transition. Defects in this gene are a cause of chromosome 9q subtelomeric deletion syndrome (9q-syndrome, also known as Kleefstra syndrome). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2017]
EHMT1 Gene-Disease associations (from GenCC):
  • Kleefstra syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Kleefstra syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 9-137716669-A-T is Benign according to our data. Variant chr9-137716669-A-T is described in ClinVar as Benign. ClinVar VariationId is 96140.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.782 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.134 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EHMT1NM_024757.5 linkc.129A>T p.Ala43Ala synonymous_variant Exon 3 of 27 ENST00000460843.6 NP_079033.4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EHMT1ENST00000460843.6 linkc.129A>T p.Ala43Ala synonymous_variant Exon 3 of 27 5 NM_024757.5 ENSP00000417980.1

Frequencies

GnomAD3 genomes
AF:
0.0414
AC:
6284
AN:
151948
Hom.:
417
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.137
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0274
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000827
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.00210
Gnomad OTH
AF:
0.0330
GnomAD2 exomes
AF:
0.0122
AC:
2980
AN:
244160
AF XY:
0.00932
show subpopulations
Gnomad AFR exome
AF:
0.144
Gnomad AMR exome
AF:
0.0105
Gnomad ASJ exome
AF:
0.000431
Gnomad EAS exome
AF:
0.0000546
Gnomad FIN exome
AF:
0.000188
Gnomad NFE exome
AF:
0.00207
Gnomad OTH exome
AF:
0.0101
GnomAD4 exome
AF:
0.00559
AC:
8091
AN:
1446152
Hom.:
413
Cov.:
31
AF XY:
0.00508
AC XY:
3640
AN XY:
717108
show subpopulations
African (AFR)
AF:
0.150
AC:
4955
AN:
33040
American (AMR)
AF:
0.0124
AC:
546
AN:
43870
Ashkenazi Jewish (ASJ)
AF:
0.000237
AC:
6
AN:
25360
East Asian (EAS)
AF:
0.0000254
AC:
1
AN:
39424
South Asian (SAS)
AF:
0.000457
AC:
39
AN:
85380
European-Finnish (FIN)
AF:
0.0000961
AC:
5
AN:
52046
Middle Eastern (MID)
AF:
0.0220
AC:
125
AN:
5678
European-Non Finnish (NFE)
AF:
0.00152
AC:
1679
AN:
1101748
Other (OTH)
AF:
0.0123
AC:
735
AN:
59606
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
410
820
1230
1640
2050
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
182
364
546
728
910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0414
AC:
6296
AN:
152066
Hom.:
416
Cov.:
32
AF XY:
0.0402
AC XY:
2991
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.137
AC:
5650
AN:
41392
American (AMR)
AF:
0.0274
AC:
419
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.0374
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
0.00210
AC:
143
AN:
67960
Other (OTH)
AF:
0.0327
AC:
69
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
260
521
781
1042
1302
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0132
Hom.:
32
Bravo
AF:
0.0481
Asia WGS
AF:
0.00808
AC:
28
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Apr 03, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 15, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Kleefstra syndrome 1 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Apr 15, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.28
BayesDel_noAF
Benign
-0.75
CADD
Benign
3.0
DANN
Benign
0.85
PhyloP100
-0.78
RBP_binding_hub_radar
1.1
RBP_regulation_power_radar
2.8
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs76684726; hg19: chr9-140611121; API